Merck Prestige® 5 has been shown effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis (EEE and WEE) viruses, equine influenza virus (EIV), equine herpesvirus type 1 (EHV-1), equine herpesvirus type 4 (EHV-4), and tetanus. Duration of immunity has been shown at 6 months for EIV. Duration of immunity for Eastern and Western encephalomyelitis viruses, EHV-1, EHV-4 and tetanus has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov. This product has been shown to be effective against virus shedding of EIV and EHV-1. Multiple antigen combination reduces need for several injections. it is formulated to minimize reactions and maximize protection. Provides 6 months of protection against EIV. A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus – flavivirus chimera and tetanus toxoid.
|Availability||Buy In Store|
|Directions For Use||Horses >=6 months of age: 1 mL repeat in 3-4 weeks. Presence of maternal antibody is known to interfere with development of active immunity in foals & additional boosters will be administered in most young animals. Consult veterinarian revaccination.|
|Ingredients||Gentamicin, not named, thimerosal|
|Size||1 ml (1 dose)|
There are no reviews yet.